Insulin therapy alone is often not enough for people with T1D to achieve glucose and metabolic control
Generic or undated COAs, or those from in-house labs only, are insufficient verification
Men are statistically less likely to seek weight loss treatment despite having similar obesity rates to women
Tirzepatide vs Semaglutide vs Retatrutide Semaglutide: Targets 1 receptor (GLP-1) commonly used as a first-line option Tirzepatide: Targets 2 receptors (GLP-1 + GIP) suitable for enhanced appetite control Retatrutide: Targets 3 receptors a newer, more advanced multi-pathway option Cost & Availability Typical cost: 400 per kit (approx
Book your free consultation today and let our team help you navigate postpartum health, safely, effectively, and with care
Once you stop taking Wegovy, weight regain is common, especially if lifestyle modifications are not maintained